TreeWAS – Variant ID: rs2867695

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I10 Essential (primary) hypertension	0.000	0.002	0.998
I10-I15 Hypertensive diseases	0.000	0.728	0.272
I15 Secondary hypertension	0.000	0.800	0.200
I11 Hypertensive heart disease	0.000	0.803	0.197
I13 Hypertensive heart and renal disease	0.000	0.805	0.195
I15.1 Hypertension secondary to other renal disorders	0.000	0.834	0.165
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.855	0.145
I15.9 Seconday hypertension, unspecified	0.000	0.856	0.144
I15.8 Other secondary hypertension	0.000	0.856	0.144
I15.2 Hypertension secondary to endocrine disorders	0.000	0.856	0.144
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.860	0.140
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.860	0.140
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.860	0.140
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.860	0.140
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.861	0.139
I15.0 Renovascular hypertension	0.000	0.882	0.118
I12 Hypertensive renal disease	0.000	0.892	0.108
I12.9 Hypertensive renal disease without renal failure	0.000	0.929	0.071
N18.9 Chronic renal failure, unspecified	0.028	0.972	0.000
N19 Unspecified renal failure	0.028	0.972	0.000
N18 Chronic renal failure	0.025	0.975	0.000
N17-N19 Renal failure	0.024	0.976	0.000
N18.0 End-stage renal disease	0.021	0.979	0.000
N18.2 Chronic kidney disease, stage 2	0.021	0.979	0.000
J39.2 Other diseases of pharynx	0.020	0.980	0.000
N50.8 Other specified disorders of male genital organs	0.000	0.980	0.020
N18.1 Chronic kidney disease, stage 1	0.018	0.982	0.000
N18.8 Other chronic renal failure	0.018	0.982	0.000
J39 Other diseases of upper respiratory tract	0.017	0.983	0.000
N17 Acute renal failure	0.017	0.983	0.000
N18.4 Chronic kidney disease, stage 4	0.017	0.983	0.000
J39.8 Other specified diseases of upper respiratory tract	0.016	0.984	0.000
N18.5 Chronic kidney disease, stage 5	0.016	0.984	0.000
J39.0 Retropharyngeal and parapharyngeal abscess	0.014	0.986	0.000
N17.0 Acute renal failure with tubular necrosis	0.014	0.986	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.013	0.986	0.000
I12.0 Hypertensive renal disease with renal failure	0.000	0.987	0.013
N18.3 Chronic kidney disease, stage 3	0.013	0.987	0.000
J39.9 Disease of upper respiratory tract, unspecified	0.012	0.988	0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.012	0.988	0.000
J39.1 Other abscess of pharynx	0.012	0.988	0.000
N17.8 Other acute renal failure	0.012	0.988	0.000
N17.2 Acute renal failure with medullary necrosis	0.012	0.988	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.989	0.011
R59.9 Enlarged lymph nodes, unspecified	0.011	0.989	0.000
R59.1 Generalised enlarged lymph nodes	0.010	0.990	0.000
R59 Enlarged lymph nodes	0.010	0.990	0.000
N50 Other disorders of male genital organs	0.000	0.990	0.010
R59.0 Localised enlarged lymph nodes	0.009	0.991	0.000
Z45.2 Adjustment and management of vascular access device	0.008	0.992	0.000
N50.9 Disorder of male genital organs, unspecified	0.000	0.992	0.008
G47.9 Sleep disorder, unspecified	0.000	0.993	0.007
N50.1 Vascular disorders of male genital organs	0.000	0.993	0.007
I80.2 Phlebitis and thrombophlebitis of other deep vessels of lower extremities	0.007	0.993	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.993	0.007
N50.0 Atrophy of testis	0.000	0.993	0.007
D86 Sarcoidosis	0.000	0.995	0.005
G47 Sleep disorders	0.000	0.995	0.005
E55.9 Vitamin D deficiency, unspecified	0.000	0.995	0.005
D86.0 Sarcoidosis of lung	0.000	0.995	0.005
D86.8 Sarcoidosis of other and combined sites	0.000	0.995	0.005
G47.3 Sleep apnoea	0.000	0.995	0.005
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.005	0.995	0.000
R20.2 Paraesthesia of skin	0.000	0.996	0.004
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
G47.1 Disorders of excessive somnolence [hypersomnias]	0.000	0.996	0.004
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.000	0.996	0.004
D86.3 Sarcoidosis of skin	0.000	0.996	0.004
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.996	0.004
G47.4 Narcolepsy and cataplexy	0.000	0.996	0.004
G47.2 Disorders of the sleep-wake schedule	0.000	0.996	0.004
N17.9 Acute renal failure, unspecified	0.004	0.996	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.996	0.004
B37.8 Candidiasis of other sites	0.004	0.996	0.000
D52.9 Folate deficiency anaemia, unspecified	0.003	0.996	0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.000	0.997	0.003
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
D05.1 Intraductal carcinoma in situ	0.000	0.997	0.003
R09.1 Pleurisy	0.000	0.997	0.003
J33.8 Other polyp of sinus	0.003	0.997	0.000
Z45 Adjustment and management of implanted device	0.003	0.997	0.000
Z45.8 Adjustment and management of other implanted devices	0.003	0.997	0.000
I07.1 Tricuspid insufficiency	0.000	0.997	0.003
C82.0 Small cleaved cell, follicular	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
C82.2 Large cell, follicular	0.003	0.997	0.000
C82.6 Cutaneous follicle centre lymphoma	0.003	0.997	0.000
C82.5 Diffuse follicle centre lymphoma	0.003	0.997	0.000
C82.4 Follicular lymphoma grade IIIb	0.003	0.997	0.000
C82.3 Follicular lymphoma grade IIIa	0.003	0.997	0.000
B02.9 Zoster without complication	0.003	0.997	0.000
E55 Vitamin D deficiency	0.000	0.997	0.003
B44.1 Other pulmonary aspergillosis	0.003	0.997	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.003	0.997	0.000
Z45.1 Adjustment and management of infusion pump	0.003	0.997	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.003	0.997	0.000
G47.8 Other sleep disorders	0.000	0.997	0.002
I25.5 Ischaemic cardiomyopathy	0.000	0.997	0.003
Z45.9 Adjustment and management of unspecified implanted device	0.002	0.997	0.000
Z45.3 Adjustment and management of implanted hearing device	0.002	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
I25 Chronic ischaemic heart disease	0.000	0.997	0.003
B44 Aspergillosis	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
B37 Candidiasis	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
B37.2 Candidiasis of skin and nail	0.002	0.998	0.000
I25.3 Aneurysm of heart	0.000	0.998	0.002
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.998	0.002
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
E55.0 Rickets, active	0.000	0.998	0.002
K81.9 Cholecystitis, unspecified	0.002	0.998	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.998	0.002
C81.1 Nodular sclerosis	0.002	0.998	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
B35-B49 Mycoses	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
E83.3 Disorders of phosphorus metabolism	0.002	0.998	0.000
B44.9 Aspergillosis, unspecified	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
B37.4 Candidiasis of other urogenital sites	0.002	0.998	0.000
I25.6 Silent myocardial ischaemia	0.000	0.998	0.002
Q61.3 Polycystic kidney, unspecified	0.000	0.998	0.002
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.998	0.002
I42.9 Cardiomyopathy, unspecified	0.000	0.998	0.002
B35 Dermatophytosis	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.002	0.998	0.000
I25.4 Coronary artery aneurysm	0.000	0.998	0.002
B44.8 Other forms of aspergillosis	0.002	0.998	0.000
B44.7 Disseminated aspergillosis	0.002	0.998	0.000
B44.2 Tonsillar aspergillosis	0.002	0.998	0.000
B44.0 Invasive pulmonary aspergillosis	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.002	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.002	0.998	0.000
C81.3 Lymphocytic depletion	0.002	0.998	0.000
C81.2 Mixed cellularity	0.002	0.998	0.000
C81.0 Lymphocytic predominance	0.002	0.998	0.000
R63.8 Other symptoms and signs concerning food and fluid intake	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.998	0.002
Z73.3 Stress, not elsewhere classified	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.998	0.000
B18 Chronic viral hepatitis	0.002	0.998	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.002	0.998	0.000
Q61.0 Congenital single renal cyst	0.000	0.998	0.002
B35.1 Tinea unguium	0.002	0.998	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.998	0.002
S72.00 Fracture of neck of femur (closed)	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
Z30.1 Insertion of (intra-uterine) contraceptive device	0.000	0.998	0.002
B35.6 Tinea cruris	0.002	0.998	0.000
B37.7 Candidal septicaemia	0.002	0.998	0.000
B37.6 Candidal endocarditis	0.002	0.998	0.000
B37.5 Candidal meningitis	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
B15-B19 Viral hepatitis	0.002	0.998	0.000
D12.3 Transverse colon	0.002	0.998	0.000
B02 Zoster [herpes zoster]	0.002	0.998	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.998	0.002
B17 Other acute viral hepatitis	0.002	0.998	0.000
B48 Other mycoses, not elsewhere classified	0.002	0.998	0.000
B47 Mycetoma	0.002	0.998	0.000
B46 Zygomycosis	0.002	0.998	0.000
B45 Cryptococcosis	0.002	0.998	0.000
B43 Chromomycosis and phaeomycotic abscess	0.002	0.998	0.000
B42 Sporotrichosis	0.002	0.998	0.000
B41 Paracoccidioidomycosis	0.002	0.998	0.000
B40 Blastomycosis	0.002	0.998	0.000
B39 Histoplasmosis	0.002	0.998	0.000
B38 Coccidioidomycosis	0.002	0.998	0.000
B36 Other superficial mycoses	0.002	0.998	0.000
B17.1 Acute hepatitis C	0.002	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.002	0.998	0.000
C93.7 Other monocytic leukaemia	0.002	0.998	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.998	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.998	0.000
C93.0 Acute monocytic leukaemia	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
R10.2 Pelvic and perineal pain	0.002	0.998	0.000
Q61 Cystic kidney disease	0.000	0.998	0.002
S32.40 Fracture of acetabulum (closed)	0.000	0.998	0.002
A63.0 Anogenital (venereal) warts	0.002	0.998	0.000
I33.0 Acute and subacute infective endocarditis	0.002	0.998	0.000
B15 Acute hepatitis A	0.002	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.998	0.000
B35.9 Dermatophytosis, unspecified	0.002	0.998	0.000
B35.8 Other dermatophytoses	0.002	0.998	0.000
B35.5 Tinea imbricata	0.002	0.998	0.000
B35.4 Tinea corporis	0.002	0.998	0.000
B35.2 Tinea manuum	0.002	0.998	0.000
B35.0 Tinea barbae and tinea capitis	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.002	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.002	0.998	0.000
C88.2 Gamma heavy chain disease	0.002	0.998	0.000
C88.1 Alpha heavy chain disease	0.002	0.998	0.000
K12.1 Other forms of stomatitis	0.002	0.998	0.000
Q27.3 Peripheral arteriovenous malformation	0.002	0.998	0.000
D84 Other immunodeficiencies	0.000	0.998	0.002
D80 Immunodeficiency with predominantly antibody defects	0.000	0.998	0.002
B18.2 Chronic viral hepatitis C	0.002	0.998	0.000
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions	0.002	0.998	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.002	0.998	0.000
D07.5 Prostate	0.000	0.998	0.002
B19 Unspecified viral hepatitis	0.002	0.998	0.000
B37.3 Candidiasis of vulva and vagina	0.002	0.998	0.000
B37.1 Pulmonary candidiasis	0.001	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.998	0.000
C94.7 Other specified leukaemias	0.001	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.998	0.000
C94.5 Acute myelofibrosis	0.001	0.998	0.000
C94.4 Acute panmyelosis	0.001	0.998	0.000
C94.3 Mast cell leukaemia	0.001	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.998	0.000
C94.1 Chronic erythraemia	0.001	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.998	0.000
C95.9 Leukaemia, unspecified	0.001	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.998	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.998	0.000
C96.8 Histiocytic sarcoma	0.001	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.998	0.000
C96.3 True histiocytic lymphoma	0.001	0.998	0.000
C96.2 Malignant mast cell tumour	0.001	0.998	0.000
C96.1 Malignant histiocytosis	0.001	0.998	0.000
C96.0 Letterer-Siwe disease	0.001	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
D83 Common variable immunodeficiency	0.000	0.998	0.002
D82 Immunodeficiency associated with other major defects	0.000	0.998	0.002
D81 Combined immunodeficiencies	0.000	0.998	0.002
A40.1 Septicaemia due to streptococcus, group B	0.002	0.998	0.000
B02.3 Zoster ocular disease	0.002	0.998	0.000
B15.9 Hepatitis A without hepatic coma	0.002	0.998	0.000
B18.9 Chronic viral hepatitis, unspecified	0.002	0.998	0.000
B18.8 Other chronic viral hepatitis	0.002	0.998	0.000
B18.0 Chronic viral hepatitis B with delta-agent	0.002	0.998	0.000
S64.4 Injury of digital nerve of other finger	0.000	0.998	0.002
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.002	0.998	0.000
S81.8 Open wound of other parts of lower leg	0.002	0.998	0.000
D52 Folate deficiency anaemia	0.002	0.998	0.000
F45.8 Other somatoform disorders	0.002	0.998	0.000
B02.8 Zoster with other complications	0.001	0.998	0.000
B02.7 Disseminated zoster	0.001	0.998	0.000
B02.1 Zoster meningitis	0.001	0.998	0.000
B02.0 Zoster encephalitis	0.001	0.998	0.000
B23.8 HIV disease resulting in other specified conditions	0.001	0.998	0.000
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.002	0.998	0.000
H74.4 Polyp of middle ear	0.002	0.998	0.000
W25.9 Unspecified place	0.002	0.998	0.000
B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases	0.001	0.998	0.000
B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms	0.001	0.998	0.000
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases	0.001	0.998	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.998	0.001
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.002	0.998	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
R09 Other symptoms and signs involving the circulatory and respiratory systems	0.000	0.998	0.002
A50-A64 Infections with a predominantly sexual mode of transmission	0.002	0.998	0.000
B17.9 Acute viral hepatitis, unspecified	0.001	0.998	0.000
B17.8 Other specified acute viral hepatitis	0.001	0.998	0.000
B17.2 Acute hepatitis E	0.001	0.998	0.000
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.001	0.998	0.000
B36.9 Superficial mycosis, unspecified	0.001	0.998	0.000
B36.8 Other specified superficial mycoses	0.001	0.998	0.000
B36.3 Black piedra	0.001	0.998	0.000
B36.2 White piedra	0.001	0.998	0.000
B36.1 Tinea nigra	0.001	0.998	0.000
B36.0 Pityriasis versicolor	0.001	0.998	0.000
B38.9 Coccidioidomycosis, unspecified	0.001	0.998	0.000
B38.8 Other forms of coccidioidomycosis	0.001	0.998	0.000
B38.7 Disseminated coccidioidomycosis	0.001	0.998	0.000
B38.4 Coccidioidomycosis meningitis	0.001	0.998	0.000
B38.3 Cutaneous coccidioidomycosis	0.001	0.998	0.000
B38.2 Pulmonary coccidioidomycosis, unspecified	0.001	0.998	0.000
B38.1 Chronic pulmonary coccidioidomycosis	0.001	0.998	0.000
B38.0 Acute pulmonary coccidioidomycosis	0.001	0.998	0.000
B39.9 Histoplasmosis, unspecified	0.001	0.998	0.000
B39.5 Histoplasmosis duboisii	0.001	0.998	0.000
B39.4 Histoplasmosis capsulati, unspecified	0.001	0.998	0.000
B39.3 Disseminated histoplasmosis capsulati	0.001	0.998	0.000
B39.2 Pulmonary histoplasmosis capsulati, unspecified	0.001	0.998	0.000
B39.1 Chronic pulmonary histoplasmosis capsulati	0.001	0.998	0.000
B39.0 Acute pulmonary histoplasmosis capsulati	0.001	0.998	0.000
B40.9 Blastomycosis, unspecified	0.001	0.998	0.000
B40.8 Other forms of blastomycosis	0.001	0.998	0.000
B40.7 Disseminated blastomycosis	0.001	0.998	0.000
B40.3 Cutaneous blastomycosis	0.001	0.998	0.000
B40.2 Pulmonary blastomycosis, unspecified	0.001	0.998	0.000
B40.1 Chronic pulmonary blastomycosis	0.001	0.998	0.000
B40.0 Acute pulmonary blastomycosis	0.001	0.998	0.000
B41.9 Paracoccidioidomycosis, unspecified	0.001	0.998	0.000
B41.8 Other forms of paracoccidioidomycosis	0.001	0.998	0.000
B41.7 Disseminated paracoccidioidomycosis	0.001	0.998	0.000
B41.0 Pulmonary paracoccidioidomycosis	0.001	0.998	0.000
B42.9 Sporotrichosis, unspecified	0.001	0.998	0.000
B42.8 Other forms of sporotrichosis	0.001	0.998	0.000
B42.7 Disseminated sporotrichosis	0.001	0.998	0.000
B42.1 Lymphocutaneous sporotrichosis	0.001	0.998	0.000
B42.0 Pulmonary sporotrichosis	0.001	0.998	0.000
B43.9 Chromomycosis, unspecified	0.001	0.998	0.000
B43.8 Other forms of chromomycosis	0.001	0.998	0.000
B43.2 Subcutaneous phaeomycotic abscess and cyst	0.001	0.998	0.000
B43.1 Phaeomycotic brain abscess	0.001	0.998	0.000
B43.0 Cutaneous chromomycosis	0.001	0.998	0.000
B45.9 Cryptococcosis, unspecified	0.001	0.998	0.000
B45.8 Other forms of cryptococcosis	0.001	0.998	0.000
B45.7 Disseminated cryptococcosis	0.001	0.998	0.000
B45.3 Osseous cryptococcosis	0.001	0.998	0.000
B45.2 Cutaneous cryptococcosis	0.001	0.998	0.000
B45.1 Cerebral cryptococcosis	0.001	0.998	0.000
B45.0 Pulmonary cryptococcosis	0.001	0.998	0.000
B46.9 Zygomycosis, unspecified	0.001	0.998	0.000
B46.8 Other zygomycoses	0.001	0.998	0.000
B46.5 Mucormycosis, unspecified	0.001	0.998	0.000
B46.4 Disseminated mucormycosis	0.001	0.998	0.000
B46.3 Cutaneous mucormycosis	0.001	0.998	0.000
B46.2 Gastro-intestinal mucormycosis	0.001	0.998	0.000
B46.1 Rhinocerebral mucormycosis	0.001	0.998	0.000
B46.0 Pulmonary mucormycosis	0.001	0.998	0.000
B47.9 Mycetoma, unspecified	0.001	0.998	0.000
B47.1 Actinomycetoma	0.001	0.998	0.000
B47.0 Eumycetoma	0.001	0.998	0.000
B48.8 Other specified mycoses	0.001	0.998	0.000
B48.7 Opportunistic mycoses	0.001	0.998	0.000
B48.4 Penicillosis	0.001	0.998	0.000
B48.3 Geotrichosis	0.001	0.998	0.000
B48.2 Allescheriasis	0.001	0.998	0.000
B48.1 Rhinosporidiosis	0.001	0.998	0.000
B48.0 Lobomycosis	0.001	0.998	0.000
C90.3 Solitary plasmacytoma	0.001	0.998	0.000
G62.8 Other specified polyneuropathies	0.000	0.998	0.002
B19.9 Unspecified viral hepatitis without coma	0.001	0.998	0.000
D69.6 Thrombocytopenia, unspecified	0.002	0.998	0.000
D84.9 Immunodeficiency, unspecified	0.000	0.998	0.001
Q61.8 Other cystic kidney diseases	0.000	0.998	0.001
Q61.5 Medullary cystic kidney	0.000	0.998	0.001
Q61.4 Renal dysplasia	0.000	0.998	0.001
Q61.1 Polycystic kidney, infantile type	0.000	0.998	0.001
S68 Traumatic amputation of wrist and hand	0.000	0.998	0.002
B15.0 Hepatitis A with hepatic coma	0.001	0.998	0.000
B35.3 Tinea pedis	0.001	0.998	0.000
B25.9 Cytomegaloviral disease, unspecified	0.001	0.998	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.998	0.001
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.998	0.001
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.998	0.001
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.998	0.001
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.998	0.001
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.998	0.001
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.998	0.001
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.998	0.001
D84.8 Other specified immunodeficiencies	0.000	0.998	0.001
D84.1 Defects in the complement system	0.000	0.998	0.001
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.998	0.001
G63.2 Diabetic polyneuropathy	0.000	0.998	0.002
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.000	0.998	0.002
B16 Acute hepatitis B	0.001	0.998	0.000
I07 Rheumatic tricuspid valve diseases	0.000	0.998	0.001
Chapter I Certain infectious and parasitic diseases	0.002	0.998	0.000
B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified	0.001	0.998	0.000
B23.1 HIV disease resulting in (persistent) generalised lymphadenopathy	0.001	0.998	0.000
B23.0 Acute HIV infection syndrome	0.001	0.998	0.000
G24.5 Blepharospasm	0.001	0.998	0.000
S81.0 Open wound of knee	0.002	0.998	0.000
R82 Other abnormal findings in urine	0.002	0.998	0.000
B19.0 Unspecified viral hepatitis with coma	0.001	0.998	0.000
B50.9 Plasmodium falciparum malaria, unspecified	0.001	0.998	0.000
Q61.9 Cystic kidney disease, unspecified	0.000	0.998	0.001
B86 Scabies	0.001	0.998	0.000
D05 Carcinoma in situ of breast	0.000	0.998	0.002
B85-B89 Pediculosis, acariasis and other infestations	0.001	0.998	0.000
B50-B64 Protozoal diseases	0.001	0.998	0.000
C90.1 Plasma cell leukaemia	0.001	0.998	0.000
D81.9 Combined immunodeficiency, unspecified	0.000	0.998	0.001
D81.8 Other combined immunodeficiencies	0.000	0.998	0.001
D81.7 Major histocompatibility complex class II deficiency	0.000	0.998	0.001
D81.6 Major histocompatibility complex class I deficiency	0.000	0.998	0.001
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.998	0.001
D81.4 Nezelof's syndrome	0.000	0.998	0.001
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.998	0.001
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.998	0.001
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.998	0.001
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.998	0.001
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.998	0.001
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.998	0.001
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.998	0.001
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.998	0.001
D82.2 Immunodeficiency with short-limbed stature	0.000	0.998	0.001
D82.1 Di George's syndrome	0.000	0.998	0.001
D82.0 Wiskott-Aldrich syndrome	0.000	0.998	0.001
D83.9 Common variable immunodeficiency, unspecified	0.000	0.998	0.001
D83.8 Other common variable immunodeficiencies	0.000	0.998	0.001
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.998	0.001
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.998	0.001
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.998	0.001
R82.7 Abnormal findings on microbiological examination of urine	0.001	0.998	0.000
B50 Plasmodium falciparum malaria	0.001	0.998	0.000
A63.8 Other specified predominantly sexually transmitted diseases	0.001	0.998	0.000
D52.8 Other folate deficiency anaemias	0.001	0.998	0.000
D52.1 Drug-induced folate deficiency anaemia	0.001	0.998	0.000
D52.0 Dietary folate deficiency anaemia	0.001	0.998	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.998	0.001
R09.2 Respiratory arrest	0.000	0.998	0.001
B25 Cytomegaloviral disease	0.001	0.998	0.000
D05.0 Lobular carcinoma in situ	0.000	0.999	0.001
B20.9 HIV disease resulting in unspecified infectious or parasitic disease	0.001	0.999	0.000
B20.8 HIV disease resulting in other infectious and parasitic diseases	0.001	0.999	0.000
B20.7 HIV disease resulting in multiple infections	0.001	0.999	0.000
B20.6 HIV disease resulting in Pneumocystis carinii pneumonia	0.001	0.999	0.000
B20.5 HIV disease resulting in other mycoses	0.001	0.999	0.000
B20.4 HIV disease resulting in candidiasis	0.001	0.999	0.000
B20.3 HIV disease resulting in other viral infections	0.001	0.999	0.000
B20.2 HIV disease resulting in cytomegaloviral disease	0.001	0.999	0.000
B20.1 HIV disease resulting in other bacterial infections	0.001	0.999	0.000
B20.0 HIV disease resulting in mycobacterial infection	0.001	0.999	0.000
B21.9 HIV disease resulting in unspecified malignant neoplasm	0.001	0.999	0.000
B21.8 HIV disease resulting in other malignant neoplasms	0.001	0.999	0.000
B21.7 HIV disease resulting in multiple malignant neoplasms	0.001	0.999	0.000
B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
B21.2 HIV disease resulting in other types of non-Hodgkin's lymphoma	0.001	0.999	0.000
B21.1 HIV disease resulting in Burkitt's lymphoma	0.001	0.999	0.000
B21.0 HIV disease resulting in Kaposi's sarcoma	0.001	0.999	0.000
B22.7 HIV disease resulting in multiple diseases classified elsewhere	0.001	0.999	0.000
B22.2 HIV disease resulting in wasting syndrome	0.001	0.999	0.000
B22.1 HIV disease resulting in lymphoid interstitial pneumonitis	0.001	0.999	0.000
B22.0 HIV disease resulting in encephalopathy	0.001	0.999	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.999	0.000
I22.8 Subsequent myocardial infarction of other sites	0.001	0.999	0.000
A60 Anogenital herpesviral [herpes simplex] infections	0.001	0.999	0.000
B49 Unspecified mycosis	0.001	0.999	0.000
B37.9 Candidiasis, unspecified	0.001	0.999	0.000
B37.0 Candidal stomatitis	0.000	0.999	0.001
S68.0 Traumatic amputation of thumb (complete)(partial)	0.000	0.999	0.001
A59 Trichomoniasis	0.001	0.999	0.000
A56 Other sexually transmitted chlamydial diseases	0.001	0.999	0.000
A54 Gonococcal infection	0.001	0.999	0.000
A53 Other and unspecified syphilis	0.001	0.999	0.000
A52 Late syphilis	0.001	0.999	0.000
A51 Early syphilis	0.001	0.999	0.000
A50 Congenital syphilis	0.001	0.999	0.000
A64 Unspecified sexually transmitted disease	0.001	0.999	0.000
A58 Granuloma inguinale	0.001	0.999	0.000
A57 Chancroid	0.001	0.999	0.000
A55 Chlamydial lymphogranuloma (venereum)	0.001	0.999	0.000
B25-B34 Other viral diseases	0.001	0.999	0.000
A87.9 Viral meningitis, unspecified	0.001	0.999	0.000
B02.2 Zoster with other nervous system involvement	0.001	0.999	0.000
G61.8 Other inflammatory polyneuropathies	0.000	0.999	0.001
E07.9 Disorder of thyroid, unspecified	0.001	0.999	0.000
G61.0 Guillain-Barre syndrome	0.000	0.999	0.001
K91.4 Colostomy and enterostomy malfunction	0.001	0.999	0.000
S68.9 Traumatic amputation of wrist and hand, level unspecified	0.000	0.999	0.001
S68.8 Traumatic amputation of other parts of wrist and hand	0.000	0.999	0.001
S68.4 Traumatic amputation of hand at wrist level	0.000	0.999	0.001
S68.3 Combined traumatic amputation of (part of) finger(s) with other parts of wrist and hand	0.000	0.999	0.001
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.001	0.999	0.000
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.001	0.999	0.000
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.001	0.999	0.000
I07.9 Tricuspid valve disease, unspecified	0.000	0.999	0.001
I07.8 Other tricuspid valve diseases	0.000	0.999	0.001
I07.2 Tricuspid stenosis with insufficiency	0.000	0.999	0.001
I07.0 Tricuspid stenosis	0.000	0.999	0.001
R09.0 Asphyxia	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations